Source comparison
AICAR Pathway Comparison
Some researchers have compared MOTS-c's metabolic effects to those of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-characterized pharmacological AMPK activator. Both compounds appear to increase AMPK phosphorylation and promote glucose uptake
This comparison does not assign a generated winner or score.
- Some researchers have compared MOTS-c's metabolic effects to those of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-characterized pharmacological AMPK activator. Both compounds appear to increase AMPK phosphorylation and promote glucose uptake in myocyte models, though via somewhat different upstream mechanisms. This comparison is valuable for contextualizing MOTS-c's mechanism within the known AMPK biology.